PDCD1 and neoplasm: To depict the transcriptional landscape and identify the synergistic mechanisms of combined PD-1 inhibitor and SMI therapy, we performed scRNA-seq analysis on the tumor tissues from three representative mice in each group using 10X Genomics (Fig. 3A).